Medicare Enrolled
Dr. Ming-Kong Liu, M.D.
Pulmonary Disease · Bergenfield, NJ
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Liu from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Liu?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Liu
Dr. Ming-Kong Liu is a pulmonary disease specialist in Bergenfield, NJ, with 19 years of NPI registration. Based on federal Medicare data, Dr. Liu performed 1,604 Medicare services across 908 unique beneficiaries.
Between the years covered by Open Payments, Dr. Liu received a total of $6,596 from 58 pharmaceutical and/or device companies across 427 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Liu is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 44% volume in NJ
$6,596 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,604
Medicare services
Top 44% in NJ for pulmonary disease
908
Unique beneficiaries
$67
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~84 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
603 | $88 | $240 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
406 | $5 | $5 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
128 | $69 | $160 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
125 | $144 | $395 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
91 | $34 | $70 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
89 | $71 | $90 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
45 | $54 | $165 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
24 | $113 | $300 |
| Pneumococcal conjugate vaccine (PCV20) An intramuscular injection of the 20-valent pneumococcal conjugate vaccine. It is used to protect against diseases caused by Streptococcus pneumoniae bacteria. |
22 | $282 | $395 |
| Pneumonia vaccine administration This procedure involves the injection of a vaccine to protect against pneumococcal disease. It is administered by a healthcare provider. |
22 | $34 | $70 |
| Initial preventive physical examination, new Medicare beneficiary A comprehensive preventive health visit for new Medicare beneficiaries during their first 12 months of enrollment. The service is conducted as a face-to-face visit and is limited to preventive care. |
17 | $185 | $560 |
| Chest X-ray, 2 views An X-ray imaging test of the chest that captures two different angles to visualize the lungs, heart, and chest wall. |
16 | $26 | $105 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
16 | $12 | $60 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$6,596
Total received (2018-2024)
Avg $942/year across 7 years
Top 21% in NJ for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
58
Companies
427
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,596 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$609
2023
$783
2022
$1,091
2021
$984
2020
$883
2019
$1,188
2018
$1,058
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$64
AstraZeneca Pharmaceuticals LP
$50
Actelion Pharmaceuticals US, Inc.
$49
Boehringer Ingelheim Pharmaceuticals, Inc.
$46
Mylan Specialty L.P.
$38
Lilly USA, LLC
$38
Inspire Medical Systems, Inc.
$38
Insmed, Inc.
$35
Novo Nordisk Inc
$35
GlaxoSmithKline, LLC.
$33
SANOFI-AVENTIS U.S. LLC
$31
Takeda Pharmaceuticals U.S.A., Inc.
$30
Corcept Therapeutics
$20
UCB, Inc.
$19
United Therapeutics Corporation
$18
Vifor Pharma, Inc.
$17
Xeris Pharmaceuticals, Inc.
$16
JAZZ PHARMACEUTICALS INC.
$16
Grifols USA, LLC
$14
Top 3 companies account for 26.8% of 2024 payments
All-time payments by company (2018-2024) ›
Boehringer Ingelheim Pharmaceuticals, Inc.
$703
GlaxoSmithKline, LLC.
$576
Novo Nordisk Inc
$424
Mylan Specialty L.P.
$400
Actelion Pharmaceuticals US, Inc.
$388
AstraZeneca Pharmaceuticals LP
$339
SANOFI-AVENTIS U.S. LLC
$262
Teva Pharmaceuticals USA, Inc.
$228
Lilly USA, LLC
$219
Insmed, Inc.
$208
AbbVie Inc.
$191
Sunovion Pharmaceuticals Inc.
$180
Pulmonx Corporation
$175
JAZZ PHARMACEUTICALS INC.
$163
Philips Electronics North America Corporation
$145
Amgen Inc.
$140
Merck Sharp & Dohme Corporation
$132
Genentech USA, Inc.
$126
Grifols USA, LLC
$114
PFIZER INC.
$98
Electromed, Inc.
$95
Bayer HealthCare Pharmaceuticals Inc.
$90
UCB, Inc.
$89
Janssen Pharmaceuticals, Inc
$73
Xeris Pharmaceuticals, Inc.
$71
Takeda Pharmaceuticals U.S.A., Inc.
$61
Axsome Therapeutics, Inc.
$60
GENZYME CORPORATION
$59
Allergan, Inc.
$58
Covis Pharma GmBH
$50
Regeneron Healthcare Solutions, Inc.
$48
Exact Sciences Corporation
$47
United Therapeutics Corporation
$45
Harmony Biosciences LLC
$44
Merck Sharp & Dohme LLC
$42
Shire North American Group Inc
$39
Amarin Pharma Inc.
$38
Inspire Medical Systems, Inc.
$38
HARMONY BIOSCIENCES LLC
$29
Jazz Pharmaceuticals Inc.
$24
Ultragenyx Pharmaceutical Inc.
$21
Corcept Therapeutics
$20
Abbott Laboratories
$19
Medtronic, Inc.
$17
Vifor Pharma, Inc.
$17
Mannkind Corporation
$16
Zealand Pharma US, Inc.
$16
Mallinckrodt Hospital Products Inc.
$16
Arbor Pharmaceuticals, Inc.
$15
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$15
Daiichi Sankyo Inc.
$15
Novartis Pharmaceuticals Corporation
$15
Horizon Therapeutics plc
$15
ABBVIE INC.
$14
SOBI, INC
$14
Kowa Pharmaceuticals America, Inc.
$14
Ironwood Pharmaceuticals, Inc
$14
Synergy Pharmaceuticals Inc
$12
Top 3 companies account for 25.8% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · ACTHAR · AFREZZA · AJOVY · ALVESCO · ANORO · ARALAST · AREXVY · Adempas · Arikayce · BELSOMRA · BENLYSTA · BEVESPI AEROSPHERE · BREO · BREZTRI · CHARTIS CATHETER · CYCLOSET · CYLTEZO · Cimzia · Cologuard Collection Kit · Crysvita · DUPIXENT · Dymista · EVENITY · Esbriet · FARXIGA · FASENRA · FREESTYLE LIBRE 2 · GLASSIA · GVOKE HYPOPEN · Horizant · INJECTAFER · INPEN SMART INSULIN DELIVERY SYSTEM · INSPIRE · INVOKANA · JANUVIA · JARDIANCE · KEVZARA · KRYSTEXXA · Kerendia · Kineret · Korlym · LINZESS · LONHALA MAGNAIR · Livalo · MOUNJARO · NATPARA (PARATHYROID HORMONE) · NUCALA · OFEV · OPSUMIT · ORENITRAM · Ozempic · PAXLOVID · PNEUMOVAX 23 · PREVNAR - 13 · PREVNAR 13 · PREVNAR 20 · ProAir Digihaler · Prolastin-C · Prolastin-C Liquid · Prolia · RYBELSUS · Repatha · Rybelsus · SHINGRIX · SMARTVEST · SOLIQUA · SOLIQUA 100/33 · SPIRIVA · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · Sunosi · TALTZ · TEZSPIRE · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TRULICITY · TUDORZA PRESSAIR · TYVASO · TZIELD · Tresiba · Trulance · UBRELVY · UPTRAVI · Utibron · Vascepa · Victoza · WAKIX · Wakix · Wegovy · XARELTO · XOLAIR · XYREM · XYWAV · Xolair · Xyrem · YUPELRI · Yupelri · ZEGALOGUE · Zemaira · inCourage
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Pulmonary diseases within 10 mi
641
Per 100K population
67.1
County median income
$123,715
Nearest hospital
HOLY NAME MEDICAL CENTER
2.3 mi
2.3 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Liu is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Liu experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Liu performed 603 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Liu receive payments from pharmaceutical companies?
Yes. Dr. Liu received a total of $6,596 from 58 companies across 427 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Liu's costs compare to other pulmonary diseases in Bergenfield?
Dr. Liu's average Medicare payment per service is $67. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Liu) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Pulmonary Disease
Common procedures, typical costs, and what industry payments mean in pulmonary disease.
Same specialty & city
Pulmonary Diseases in Bergenfield
Browse pulmonary diseases in Bergenfield ranked by procedure volume and transparency data.
Highest volume
Top Pulmonary Diseases in NJ
Pulmonary diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pulmonary Diseases in NJ
Which NJ pulmonary diseases receive the most from drug and device companies.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology